Stocks Swings: The Bank of New York Mellon (NYSE:BK), YY Inc. (NASDAQ:YY), Advanced Micro Devices (NASDAQ:AMD), Merck (NYSE:MRK), Mid Penn Bancorp (NASDAQ:MPB)


On March 4, it was reported that, After announcing it was getting into the reverse mortgage business last year, The Bank of New York Mellon Corporation (NYSE:BK) is making good on its promise to start participating in the market. Though the large, New York-based bank and investment management advisor will not originate loans, the company will utilize its access to financial planners and other professionals to spread the word about reverse mortgage merits in effective retirement plans. It will also purchase and securitize loans, and is now licensed to do so. On Friday shares of The Bank of New York Mellon Corporation (NYSE:BK) closed at $39.28. Company’s sales growth for last 5 years was -1.60% and EPS growth for next 5 years is recorded as 7.30%.

YY, Inc. (NASDAQ:YY) reported Q4 EPS of $0.94, $0.10 better than the analyst estimate of $0.84. Revenue for the quarter came in at $188.7 million versus the consensus estimate of $178.64 million. YY Inc. (NASDAQ:YY) in last trading activity increased 4.69% to close at $57.76. Company weekly performance is 9.62% while its quarterly performance stands at -17.92%. YY Inc. (NASDAQ:YY) is -40.08% away from its 52 week high.

Advanced Micro Devices, Inc. (NASDAQ:AMD) has announced a new and exclusive technology for virtual reality which it claims will help increase immersion and reduce motion sickness in users, called – somewhat oddly, given it aims to prevent regurgitation – LiquidVR. On Friday shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) closed at $2.92. Company’s sales growth for last 5 years was 0.40%.

Merck & Co. Inc. (NYSE:MRK) entered into a collaboration with Eisai Co., Ltd. for the evaluation of the safety, tolerability and efficacy of Merck’s Keytruda (anti-PD-1 therapy) in combination with Eisai’s oncology compounds, including Lenvima (a multi-targeting RTK inhibitor) and Halaven (a microtubule dynamics inhibitor) across multiple studies. Merck & Co. Inc. (NYSE:MRK) in last trading activity fell -1.97% to close at $56.84. Company weekly performance is -2.90% while its quarterly performance stands at -5.47%. Merck & Co. Inc. (NYSE:MRK) is -10.66% away from its 52 week high.

Mid Penn Bancorp, Inc. (NASDAQ:MPB) announced that it has successfully completed the merger of Phoenix Bancorp, Inc., of Minersville, Pennsylvania (“Phoenix”), with Mid Penn, effective March 1, 2015, under the terms of the Agreement and Plan of Merger. Concurrently with the merger of Mid Penn and Phoenix, Phoenix’s subsidiary bank, Miners Bank, was merged into and became part of Mid Penn Bank and now operates as “Miners Bank, a Division of Mid Penn Bank.” On last trading day Mid Penn Bancorp Inc. (NASDAQ:MPB) remains unchanged to close at $15.83. Its volatility for the week is 0.08% while volatility for the month is 0.73%. MPB’s sales growth for past 5 years was -1.90% and its EPS growth for past 5 years was 5.10%. Mid Penn Bancorp Inc. (NASDAQ:MPB) monthly performance is -0.06%.


Leave a Reply

Your email address will not be published. Required fields are marked *